Currently, IHC tests are performed on most patientswith breast cancer referring to laboratories in order totest for ER, PR, E-cadherin, CK5/6, vimentin and Ki67,among which HER-2 gene amplification is examinedto prescribe and use Herceptin. This evidence concerns the gene KRT5 and breast carcinoma.